Collect Product
Product Details
Materials Provided
IDComponentsSizeRAS206-C01Pre-coated Anti-HA (Influenza B/Victoria Lineage) Antibody Microplate1 plateRAS206-C02HA (Influenza B/Victoria Lineage) Standard20 μgRAS206-C03HRP-Anti-HA (Influenza B/Victoria Lineage) Antibody20 μgRAS206-C0410×Washing Buffer50 mLRAS206-C052×Dilution Buffer50 mLRAS206-C06Substrate Solution12 mLRAS206-C07Stop Solution7 mLProduct Overview
Influenza B/Victoria Lineage Viruses Hemagglutinin (HA) Specific ELISA Kit is based on the sandwich-ELISA method and is used to specifically detect and quantitatively determine Influenza B/Victoria lineage virus HA protein in vaccine samples. The kit is designed to provide a reliable solution for the manufacturing and quality control of HA vaccine development.
Reconstitution
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
Storage
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.
The kit has been tested to specifically identify Influenza B [Austria/1359417/2021 (B/Victoria lineage)] HA, and do not identify Influenza B [Phuket/3073/2013 (B/Yamagata lineage)] HA, Influenza A [Victoria/4897/2022 (H1N1)] HA, Influenza A [Wisconsin/67/2022(H1N1)] HA, Influenza A (A/Thailand/8/2022) & (A/Massachusetts/18/2022) HA (H3N2), Influenza A [A/Darwin/6/2021 (H3N2)] HA , Influenza A [A/Darwin/9/2021 (H3N2)] HA, Influenza A [A/District of Columbia/27/2023 (H3N2)] HA and Influenza A [A/Croatia/10136RV/2023 (H3N2)] HA.
User Reviews Publish Comment
Contact Us
Drug Candidate Licensing
